Asset profile
refisolone · Vistagen Therapeutics, Inc. (VTGN)
- Indication
- vasomotor symptoms (hot flashes) due to menopause
- Also known as
- PH80
Company
VTGNVistagen Therapeutics, Inc.
VTGNVistagen Therapeutics, Inc.Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological d…
On the calendar
Nothing scheduled in this window.
Timeline
Newest first.
Material
Apr 28, 2026
08:13 PM
VTGNVistagen Therapeutics, Inc.Notable
Apr 22, 2026
12:30 PM
VTGNVistagen Therapeutics, Inc.Vistagen receives FDA Study May Proceed letter for refisolone IND
Registered trials
| Registry ID | Phase | Status | Primary completion | Enrollment | Sites |
|---|---|---|---|---|---|
| NCT01217775 | Phase 3 | Unknown | Mar 1, 2017 | 1400 | 1 of 1 sites in the United States |
More from Vistagen Therapeutics, Inc.
Other drugs and candidates from the same company tracked in this sector.